Board Member
Sera Prognostics, Inc. (SERA)Equibles does not estimate personal net worth.
Get an email with a short summary when Sera Prognostics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SERA alertsGregory Critchfield is recorded as Board Member at Sera Prognostics, Inc. (SERA) since January 1, 2010. The newest filing on record that lists Gregory Critchfield as Board Member at Sera Prognostics, Inc. (SERA) is dated April 24, 2026. Sera Prognostics, Inc. reported in an 8-K filed May 19, 2023 that Gregory Critchfield retired as Chairman of the Board of Directors, effective June 8, 2023. Sera Prognostics, Inc. reported in an 8-K filed May 19, 2023 that Gregory Critchfield retired as President and Chief Executive Officer, effective June 8, 2023. Sera Prognostics, Inc. reported in an 8-K filed May 16, 2023 that Gregory Critchfield retired as Chairman of the Board of Directors, effective June 8, 2023. Equibles holds 4 filed executive changes naming Gregory Critchfield; each is listed under recent activity with its source filing. The proxy statement of Sera Prognostics, Inc. reports total compensation of $1,512,849 for Gregory Critchfield in fiscal 2023, including a base salary of $313,023. Disclosed compensation is on record for 4 fiscal years. Gregory Critchfield has spoken on 1 earnings call across 1 company, most recently for Sera Prognostics, Inc. on March 29, 2022. Sera Prognostics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Sera Prognostics, Inc. includes Zhenya Lindgardt (CEO and Board Member), Kim Kamdar, Ph.D. (Chairman), Austin Aerts (CFO) and 7 others.
“Gregory C. Critchfield, M.D., M.S. notified the Company of his intention to retire from the position of President and Chief Executive Officer of the Company and Chairman of the Board of Directors, effective as of June 8, 2023 (the "Retirement Date").”
“Gregory C. Critchfield, M.D., M.S. notified the Company of his intention to retire from the position of President and Chief Executive Officer of the Company and Chairman of the Board of Directors, effective as of June 8, 2023 (the "Retirement Date").”
“Today I will provide an overview of key business highlights during the quarter and our expected developments over the near-term. We are pleased that Sera completed 2021 with a number of significant accomplishments that we believe will help pave the way for substantial success in the future.”
2010-01-01–present
Last confirmed April 24, 2026
Start not stated–2023-06-08
Medical Devices · Healthcare
Board Member
2010-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Sera Prognostics, Inc. (SERA) | M.D., M.S. Former Chairman, President, and Chief Executive Officer | $313,023 | $1,512,849 |
| 2022 | Sera Prognostics, Inc. (SERA) | M.D., M.S. Former Chairman, President, and Chief Executive Officer | $584,000 | $1,780,360 |
| 2021 | Sera Prognostics, Inc. (SERA) | M.D., M.S. Chairman, President, and Chief Executive Officer | $500,100 | $1,228,619 |
| 2020 | Sera Prognostics, Inc. (SERA) | M.D., M.S. Chairman, President, and Chief Executive Officer | $400,000 | $952,944 |
